Disability News and Research RSS Feed - Disability News and Research

GEMS project to explore events leading to MS in at-risk individuals

GEMS project to explore events leading to MS in at-risk individuals

A team of investigators at Brigham and Women's Hospital and the National Institute of Neurological Disorders and Stroke has launched a study of individuals at risk for multiple sclerosis (MS). By focusing on first-degree family members of MS patients, the research team seeks to better understand the sequence of events that leads some people to develop the disease. [More]
Low-income families having children with special health care needs at high risk for food insecurity

Low-income families having children with special health care needs at high risk for food insecurity

Low-income families with children who have special health care needs are at high risk for food insecurity, even when they receive Supplemental Security Income (SSI) and participate in public assistance programs, such as Supplemental Nutrition Assistance Program (SNAP) and Women, Infants, and Children (WIC). [More]
Researchers seek to better understand sequence of events that leads people to develop MS

Researchers seek to better understand sequence of events that leads people to develop MS

A team of investigators at Brigham and Women's Hospital and the National Institute of Neurological Disorders and Stroke has launched a study of individuals at risk for multiple sclerosis (MS). [More]
TBX5 gene expression could play key role in congenital heart disease

TBX5 gene expression could play key role in congenital heart disease

Congenital heart disease is the most common birth defect and the leading cause of all infant deaths in the United States. Mutations in the gene TBX5 have been shown to cause both rare and more prevalent forms of congenital heart disease, yet the underlying mechanisms have remained unclear. [More]
Study provides new insight into complex interchange that can raise blood levels of fat in type 1 diabetes

Study provides new insight into complex interchange that can raise blood levels of fat in type 1 diabetes

Researchers have new insight into the complex interchange that can raise blood levels of unhealthy lipids, or fat, in type 1 diabetes, and early evidence that a drug under study to block cancer cell growth can restore healthier levels. [More]
Pivotal IDE clinical trial results for Cerapedics' i-FACTOR bone graft in ACDF procedures published in journal Spine

Pivotal IDE clinical trial results for Cerapedics' i-FACTOR bone graft in ACDF procedures published in journal Spine

Cerapedics, a privately-held orthobiologics company, announced today results from a pivotal FDA Investigational Device Exemption (IDE) clinical trial for i-FACTOR Peptide Enhanced Bone Graft in anterior cervical discectomy and fusion (ACDF) procedures have been electronically published in the peer-reviewed journal Spine. [More]
New AGS guidance aims to transform approaches to healthcare for older patients

New AGS guidance aims to transform approaches to healthcare for older patients

New guidance from the American Geriatrics Society aims to transform approaches to healthcare for our increasingly diverse older population. Developed by a committee of experts in ethnogeriatrics (the study of how ethnicity and culture impact the health and well-being of older people), "Achieving High-Quality Multicultural Geriatric Care" outlines present health disparities and the need for sensitivity to culture and health literacy when working with older individuals. [More]
People with traumatic brain injuries may have buildup of plaques related to Alzheimer's disease

People with traumatic brain injuries may have buildup of plaques related to Alzheimer's disease

A new study suggests that people with brain injuries following head trauma may have buildup of the plaques related to Alzheimer's disease in their brains. The research is published in the February 3, 2016, online issue of Neurology, the medical journal of the American Academy of Neurology. [More]
Natalizumab shows relapse prevention benefits over fingolimod in MS

Natalizumab shows relapse prevention benefits over fingolimod in MS

Natalizumab may be superior to fingolimod for preventing relapses during the first year of treatment in patients with relapsing–remitting multiple sclerosis, observational study findings show. [More]
UAB research explores neurofibromatosis type 1

UAB research explores neurofibromatosis type 1

It is easy to tell a medical research story that has a simple and dramatic moment. But disease is often much more complex, and the work to understand it can be painstaking. A vivid example of that is seen in the University of Alabama at Birmingham Medical Genomics Laboratory, headed by Ludwine Messiaen, Ph.D., professor of genetics. This lab offers clinical genetic testing for a broad array of common and rare genetic disorders. [More]
WHO calls on governments to rate movies that portray tobacco use

WHO calls on governments to rate movies that portray tobacco use

The World Health Organization is calling on governments to rate movies that portray tobacco use in a bid to prevent children and adolescents from starting to smoke cigarettes and use other forms of tobacco. [More]
People with disabilities, caregivers, veterans and healthcare professionals to attend 2016 Abilities Expo

People with disabilities, caregivers, veterans and healthcare professionals to attend 2016 Abilities Expo

Thousands of people with disabilities, their families, caregivers, seniors, wounded veterans and healthcare professionals are expected to attend Abilities Expo on February 5-7, 2016 at the Los Angeles Convention Center, West Hall A. Admission is free and the new show hours will get attendees home in time to watch the Super Bowl: Friday 11 am to 5 pm, Saturday 10 am to 6 pm and Sunday 10 am to 2 pm. [More]
U of M's 'Ask About Aspirin' initiative aims to reduce incidence of first heart attack or stroke

U of M's 'Ask About Aspirin' initiative aims to reduce incidence of first heart attack or stroke

Cardiovascular diseases are the leading causes of death and disability in the United States, accounting for nearly one-third of all deaths. The diseases also create an immense national health economic burden. [More]

Fingolimod trial INFORMS primary progressive MS strategy

Fingolimod is unable to slow disability progression or brain volume loss in patients with primary progressive multiple sclerosis, show the findings of the INFORMS study. [More]
Clinicoradiological syndromes allow rapid recognition of EV71 neurological problems

Clinicoradiological syndromes allow rapid recognition of EV71 neurological problems

Severe enterovirus 71 neurological disease in children predominantly involves the spinal cord and brainstem and can be quickly recognised using the World Health Organisation classification of clinicoradiological syndromes, study findings suggest. [More]
Dysport phase III study results in children with cerebral palsy with lower limb spasticity published in Pediatrics

Dysport phase III study results in children with cerebral palsy with lower limb spasticity published in Pediatrics

Ipsen today announced that the scientific journal Pediatrics published the detailed results of the phase III randomized study showing both the efficacy and the safety of Dysport in the treatment of dynamic equinus foot deformity, a condition associated with cerebral palsy in children. [More]
New findings offer roadmap for development of novel therapies to target common brain disorders

New findings offer roadmap for development of novel therapies to target common brain disorders

Scientists have pinpointed the cells that are likely to trigger common brain disorders, including Alzheimer's disease, Multiple Sclerosis and intellectual disabilities. [More]
CosmosID announces $6M in Series B funding round

CosmosID announces $6M in Series B funding round

CosmosID, the leading genomic big data company focused on microbiome research, outbreak investigations, and infectious disease diagnostics, using next-generation DNA sequencing, announced $6M in Series B funding. [More]
Opioid medication does not improve physical function in patients with neuropathic pain

Opioid medication does not improve physical function in patients with neuropathic pain

Opioids such as morphine, codeine and Tylenol 3 can be effective for treating pain, however, a new University of Alberta study finds that patients with neuropathic pain taking opioids report no improvements in physical functioning compared to those who were not prescribed opioids. [More]
Twice-daily stimulation of vagus nerve with gammaCore nVNS device reduces number of migraine attacks

Twice-daily stimulation of vagus nerve with gammaCore nVNS device reduces number of migraine attacks

A study published in the Journal of Headache and Pain, carried out by Dr. Thomas Kinfe of the University of Bonn, found that twice daily stimulation of the vagus nerve with the hand-held gammaCore nVNS device reduced the number of headache days per month from 14.7 to 8.9 (p<0.001) and the number of monthly migraine attacks from 7.3 to 4.5 (p<0.001). [More]
Advertisement
Advertisement